Both companies have forward P/Es well below the average of the S&P 500, at 11.9. They also are in favor with analysts, as 2015 and 2016 earnings estimates have been moving higher.
Investors are nervous about Deckers, however, as it didn’t raise guidance last quarter. Shares have hit new 52-week lows. Teva shares have also pulled back from multi-year highs as investors have cashed in drug stock gains.
But what else should investors take away from these two companies? Watch our short video below to learn more about these value stocks!
Deckers Outdoor Corporation: http://www.zacks.com/stock/quote/DECK?cid=CS-YOUTUBE-FT-VID
Teva Pharmaceuticals: http://www.zacks.com/stock/quote/TEVA?cid=CS-YOUTUBE-FT-VID
Follow us on StockTwits: http://stocktwits.com/ZacksResearch
Follow us on Twitter: https://twitter.com/ZacksResearch
Like us on Facebook: https://www.facebook.com/ZacksInvestmentResearch